Emergence Delirium, Postoperative Nausea and Vomiting, Post Operative Pain
Conditions
Keywords
dexmedetomidine, nausea and vomiting
Brief summary
this study will aim to evaluate the effects of dexmedetomidine, dexamethasone and Ondansetron on the prevention of postoperative nausea and vomiting in children undergoing dental rehabilitation surgery.
Detailed description
Postoperative nausea and vomiting (PONV) is one of the most common and unpleasant postoperative complications, which is a major concern in surgical patients. PONV affects about 20-40% of surgical patients, with certain high-risk patients experiencing rates of up to 80%. It has a high incidence in children, especially for tonsillectomy and dental surgery. PONV could lead to several adverse consequences, including dehydration, electrolyte imbalance, and wound dehiscence. it has also been reported PONV is associated with delayed hospital discharge, unplanned hospital admission, and increased financial costs required for patient care. Several anti-emetic drugs have been described for the prophylactic control of PONV. Dexamethasone is common practice in surgery, as part of a multimodal pain and antiemetic strategy. Ondansetron is a selective 5-HT3 receptor antagonist that exhibits an anti-emetic action by antagonizing vomiting signals in the afferent pathway from the stomach or small intestine and solitary tract nucleus and is effective at preventing PONV, however, the high cost of this drug has prevented it from being widely used. Dexmedetomidine is a highly selective α2-adrenoreceptor agonist which has been widely used in clinical practice and has been explored extensively in the pediatric population due to its beneficial effects on perioperative morbidities. In the past few years, many studies in paediatrics have been published showing that dexmedetomidine lowered postoperative pain scores and opioid consumption, decreased the incidence of emergence agitation (EA), and improved the quality of recovery in pediatric patients undergoing different surgical procedures. In addition, a small selection of studies reported that dexmedetomidine could lower the incidence of nausea or vomiting after surgery and during the use of patient-controlled analgesia (PCA) in paediatrics. However, the effect of dexmedetomidine on PONV remains poorly understood. In this study, investigators will evaluate the effect of dexmedetomidine on preventing postoperative nausea and vomiting in children in comparison with dexamethasone and ondansetron
Interventions
DRUGDexamethasone
patients will receive dexamethasone (0.15 mg/kg IV; maximum 5 mg)
DRUGOndansetron
patients will receive ondansetron (0.05 mg/kg IV; maximum 4 mg)
DRUGDexmedetomidine
Patients will receive dexmedetomidine (0.3 μg/kg)
DRUGnormal Saline
patients will receive normal saline.
Sponsors
Tanta University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
Yes
Inclusion criteria
* Pediatric patients 6-12 years. * Pediatric patients (ASA physical status I, II). * Scheduled for dental rehabilitation surgery
Exclusion criteria
* Parental refusal * Allergy or contraindication to studied medication or anaesthetic agents. * Children with known gastroesophageal reflux disease. * Intake of antiemetic medication within 24 hours before surgery. * Past history or family history of previous postoperative nausea and vomiting.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who will develop postoperative nausea and vomiting and rate of development | 24 hours | Postoperative vomiting will be recorded by a nurse who will be blinded to study conditions. It will be treated if vomiting occurred more than twice in 2 minutes with granisetron (0.1mg/kg and repeated if necessary but not in less than 12 hours). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain | 24 hours | Postoperative pain will be assessed at 1st, 2nd, 4th, 8th, 12th, 16th and 24th hrs. Postoperative by using the Pediatric Objective Pain Scale, where each criterion scores 0 - 2 to give a total score 0 - 10, and a total score of less than 5 mean adequate analgesia |
| Emergence delirium | 15 minutes | Emergence delirium using the pediatric anesthesia emergence delirium (PAED) scale at four-time points: T0: after extubation; T1: 5 min after extubation; T2: 10 min after extubation; T3: 15 min extubation. The PAED scale contains five items: eye contact, the purposefulness of actions, awareness of surroundings, restlessness and consolability. Each item will be scored into five grades (0-4) according to a degree, giving a maximum total of 20 points. Patients with severe agitation defined as a PAED score ≥ 10 will be treated with intravenous propofol (1 mg/kg) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Total granisetron dose given | 24 hours | If vomiting occurred more than twice in 2 minutes will be treated with granisetron (0.1mg/kg and repeated if necessary but not in less than 12 hours). |
| Number of participants with the following side effects | 24 hours | Number of participants that will develop bradycardia, hypotension or high blood glucose |
Countries
Saudi Arabia
Outcome results
None listed